9:30am ET
Investing
Cowen Raises Price Targets on Top Momentum Stocks
These four companies are not only delivering the goods when it comes to earnings and growth prospects, but leading their respective industries in innovation.
Companies
/Healthcare
Biomarin Pharmaceutical Inc
$64.67
▼ $0.63 (−0.96%) today
Markets closed · 8:58am ET
BMRN Coverage
Page 9
3:01pm ET
Health and Healthcare
Why 1 Analyst Sees Over 50% Upside in Sarepta
Sarepta Therapeutics received a favorable rating from Merrill Lynch, and as a result the stock soared in Tuesday's trading session.
2:43pm ET
Health and Healthcare
Analyst Sees BioMarin Up Another 25%
BioMarin Pharmaceutical received a favorable analyst call from Merrill Lynch in Monday.
Chris Lange 9:25am ET
Health and Healthcare
Portfolio Managers Love These 5 Biotech Stocks
Here are the five biotech stocks that are loved the most by portfolio managers, according to Cowen analysts.
8:40am ET
Investing
Top Analyst Upgrades and Downgrades: Alcatel-Lucent, ADM, BofA, Chesapeake, Google, J.P. Morgan, MGM and More
Thursday's top analyst upgrades, downgrades and initiations seen from Wall Street research calls includes Alcatel-Lucent, ADM, Bank of America, Chesapeake Energy, Google, J.P. Morgan and MGM.
2:51pm ET
Health and Healthcare
Wells Fargo’s Top Biotech Stocks for 2015
ThinkstockLooking back at 2014, biotechs had a phenomenal year, and this looks to continue into 2015. The NYSE Arca Biotech index was up over 45% for 2014, and Wells Fargo expects that…
7:45am ET
Health and Healthcare
The Best Performing Biotech Stocks of 2014: Amazing 300% Gainers
Out of 28 biotech stocks with market capitalization rates north of $300 million that were up 100% or more in 2014, seven of them were up 300% or more.
Jon C. Ogg 9:50am ET
Health and Healthcare
RBC’s 5 Top Biotech Stocks to Buy for 2015
One sector that could be poised to do well could be the biotech arena, and the team at RBC has five top stocks for investors to focus on as best ideas.
8:40am ET
Investing
RBC Has Three Top Biotech Picks for Year End and 2015
ThinkstockIf any sector has had an up and down 2014, it would be the biotech. A massive sell-off in the spring and in the fall has given some biotech investors a serious…
9:15am ET
Health and Healthcare
Big News for Ebola Stocks
Monday may have started out as a fairly quiet news day for most stock sectors on a shortened week, but don't tell that to the Ebola drug stocks.
8:45am ET
Investing
Top Analyst Upgrades and Downgrades: BioMarin, BP, Genworth, Petrobras, Target and More
Monday's top analyst upgrades, downgrades and initiations include BioMarin Pharmaceutical, BP, Home Depot, Petrobras and Target.
8:35am ET
Health and Healthcare
5 Orphan Drug Biotech Stocks to Buy With Big Upside Potential
For many of the top biotech companies, orphan drugs have morphed into huge winners and have even generated other streams of revenue.
11:50am ET
Health and Healthcare
Credit Suisse Positive on Some Biotechs, Very Cautious on Others
Credit Suisse has launched new biotech coverage on Wednesday with two analysts at the firm.
9:15am ET
Health and Healthcare
Analyst Issues Top Biotech Stocks to Buy Ahead of Earnings
ThinkstockFor the third time in less than two weeks, one of the top brokerage firms we cover at 24/7 Wall Street has loudly stepped up to the plate and advised investors to buy…
8:40am ET
Health and Healthcare
UBS Very Bullish on Biotech Stocks Ahead of Second-Quarter Earnings
In a new research report, UBS analysts are very positive on some top biotech stocks before second-quarter earnings numbers hit the tape.